SCHEMBL5720197

SCHEMBL5720197

Cc1ccccc1CN1CCC(N2CCC(c3cc4c(cc3Br)[N]C(=O)N4)CC2)CC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 9/20 0.51
DRD2 P14416 2/20 0.51
CHRM2 P08172 1/20 0.51
CHRM4 P08173 1/20 0.51
CHRM5 P08912 1/20 0.51
CHRM3 P20309 1/20 0.51
ADRA1D P25100 1/20 0.51
HTR2C P28335 1/20 0.51
ADRA1A P35348 1/20 0.51
ADRA1B P35368 1/20 0.51
ALDH1A1 P00352 2/20 0.42
TSHR P16473 1/20 0.42
RECQL P46063 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ACHE P22303 1/20 0.41
TRPC5 Q9UL62 1/20 0.39
OPRM1 P35372 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720092 0.84 CHRM1 (0.51) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720001 0.84 ALDH1A1 (0.34) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720125 0.76 CHRM1 (0.41) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720132 0.74 TRPV6 (0.41) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720263 0.73 CHRM1 (0.38) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720312 0.73 DRD2 (0.40) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720385 0.71 CHRM1 (0.53) CHRM1DRD2ALDH1A1RECQLKMT2A
SCHEMBL5478755 0.69 CHRM1 (0.79) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720129 0.68 TLR9 (0.35) DRD2ALDH1A1TSHRRECQLL3MBTL1
SCHEMBL5720269 0.68 DRD2 (0.39) DRD2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515722-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2006-06-21 EP claimed
EP-1515722-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2005-03-23 EP claimed
WO-2003105781-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2003-12-24 WO claimed
EP-1515722-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2006-06-21 EP disclosed
EP-1515722-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2005-03-23 EP disclosed
WO-2003105781-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2003-12-24 WO disclosed